📢 𝐉𝐔𝐒𝐓 𝐈𝐍: $Clearmind Medicine(CMND.US) Clearmind Medicine Secures U.S. Patent for MEAI Binge Behavior Treatment
👉 𝐊𝐞𝐲 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬:➤ 𝐂𝐥𝐞𝐚𝐫𝐦𝐢𝐧𝐝 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞 received 𝐔.𝐒. Patent No. 𝟏𝟐,𝟑𝟓𝟕,𝟓𝟗𝟎.➤ Patent covers 𝐌𝐄𝐀𝐈 and related 2-aminoindane derivatives for binge behavior regulation.➤ Technology targets 𝐞𝐱𝐜𝐞𝐬𝐬𝐢𝐯𝐞 𝐝𝐫𝐢𝐧𝐤𝐢𝐧𝐠, overeating, and other compulsive disorders.➤ New patent expands protection beyond previously granted 𝐔.𝐒. Patent No. 𝟏𝟐,𝟑𝟓𝟎,𝟐𝟒𝟐.➤ Clearmind's IP portfolio now includes 𝟏𝟗 patent families and 𝟑𝟐 granted patents.👉 𝐖𝐡𝐲 𝐈𝐭 𝐌𝐚𝐭𝐭𝐞𝐫𝐬:➤ Strengthens Clearmind's 𝐢𝐧𝐭𝐞𝐥𝐥𝐞𝐜𝐭𝐮𝐚𝐥 𝐩𝐫𝐨𝐩𝐞𝐫𝐭𝐲 protection for MEAI.➤ Expands exclusivity for therapies targeting 𝐚𝐝𝐝𝐢𝐜𝐭𝐢𝐨𝐧 and compulsive behaviors.➤ Broader patent coverage may enhance future 𝐥𝐢𝐜𝐞𝐧𝐬𝐢𝐧𝐠 and commercialization opportunities.
Share your thoughtsWhat's on your mind?
0 / 2,000